Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Contact information

Email
ruth.coleman@ocdem.ox.ac.uk

Telephone
+44 (0)1865 857253

Website
http://www.dtu.ox.ac.uk/staff/RuthColeman.php

Research groups

Adler Group: Diabetes Trials Unit

Ruth Coleman

MSc

Senior Research Statistician

Recent publications

Can the Cardiovascular Risk Reductions Observed with Empagliflozin in the EMPA-REG OUTCOME Trial be Explained by Concomitant Changes Seen in Conventional Cardiovascular Risk Factor Levels?
Journal article

Coleman RL. et al, (2020), Diabetes Obes Metab
Time-varying risk of microvascular complications in latent autoimmune diabetes of adulthood compared with type 2 diabetes in adults: a post-hoc analysis of the UK Prospective Diabetes Study 30-year follow-up data (UKPDS 86).
Journal article

Maddaloni E. et al, (2020), Lancet Diabetes Endocrinol, 8, 206 - 215
Meta-analysis of the impact of alpha-glucosidase inhibitors on incident diabetes and cardiovascular outcomes
Journal article

Coleman RL. et al, (2019), Cardiovascular Diabetology, 18
Estimating cardiovascular risk and all-cause mortality in individuals with type 2 diabetes using the UKPDS Outcomes Model
Conference paper

Coleman RL. et al, (2019), DIABETOLOGIA, 62, S152 - S152
Long-term risk of cardiovascular disease in individuals with latent autoimmune diabetes in adults (UKPDS 85).
Journal article

Maddaloni E. et al, (2019), Diabetes Obes Metab, 21, 2115 - 2122

More publications